Baxter International to buy Baxa Corp for $380 million
26 Aug 2011
US drug and medical-products maker Baxter International Inc yesterday agreed to pay $380 million in cash to buy Baxa Corp, a drug delivery company in a bid to further expand its nutrition and drug delivery portfolio.
Baxa, a privately held company based in Englewood, Colorado, with additional operations in Florida and the UK, develops pharmacy technology that enhances the efficiency and safety of oral and IV dose preparation and delivery.
Among Baxa's numerous products are the ExactaMix Compounder, devices that automate multi-ingredient nutritional solution compounding and the DoseEdge Pharmacy Workflow Manager, an integrated system for managing IV and oral dose preparation activities.
Baxa's pharmacy integration and automation technology allow hospital pharmacists to customize treatment for specific patient when needed.
Baxa, owned and run by the Baldwin family, had 2010 annual sales of approximately $150 million.
"With these new offerings, Baxter will be able to provide a comprehensive solution to fulfill the majority of patients' nutritional requirements and increase efficiency in the pharmacy," said Robert Davis, president of Baxter's Medical Products business.
